Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM-101 for acute inner ear tinnitus
2008-005178-10Phase 2Completed
- Sponsor
- Altamira Therapeutics
- Start
- Nov 2008
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Keyzilen in tinnitus (3 arms), sponsored by Altamira Therapeutics. Started Nov 2008; status: completed.
02
Drugs
Keyzilen
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2008-005178-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005178-10.